Pyranocoumarin, a novel anti-TB pharmacophore: Synthesis and biological evaluation against Mycobacterium tuberculosis

2006 ◽  
Vol 14 (13) ◽  
pp. 4610-4626 ◽  
Author(s):  
Ze-Qi Xu ◽  
Krzysztof Pupek ◽  
William J. Suling ◽  
Livia Enache ◽  
Michael T. Flavin
2015 ◽  
Vol 2015 ◽  
pp. 1-14 ◽  
Author(s):  
Mustapha C. Mandewale ◽  
Bapu Thorat ◽  
Dnyaneshwar Shelke ◽  
Ramesh Yamgar

A new series of quinoline hydrazone derivatives and their metal complexes have been synthesized and their biological properties have been evaluated againstMycobacterium tuberculosis(H37 RV strain). Most of the newly synthesized compounds displayed 100% inhibitory activity at a concentration of 6.25–25 μg/mL, againstMycobacterium tuberculosis. Fluorescence properties of all the synthesized compounds have been studied.


2014 ◽  
Vol 12 (7) ◽  
pp. 1114-1123 ◽  
Author(s):  
Jean Bourke ◽  
Corinna F. Brereton ◽  
Stephen V. Gordon ◽  
Ed C. Lavelle ◽  
Eoin M. Scanlan

Synthetic p-hydroxybenzoic acid derivatives (p-HBADs) from Mycobacterium tuberculosis have the ability to suppress host immune response in vitro.


2016 ◽  
Vol 84 ◽  
pp. 1739-1747 ◽  
Author(s):  
Dijovani Batista dos Reis ◽  
Thalita Cristina Alves Souza ◽  
Maria Cristina S. Lourenço ◽  
Mauro Vieira de Almeida ◽  
Adriano Barbosa ◽  
...  

2022 ◽  
Author(s):  
Sampath Kumar Kancharla ◽  
Saritha Birudaraju ◽  
Arani Pal ◽  
L. Krishnakanth Reddy ◽  
RAMI REDDY EDA ◽  
...  

A series of fifteen novel isatin oxime ether-tethered aryl 1H-1,2,3-triazole hybrids 5a-o were designed and synthesized by employing Cu(I) catalyzed azide-alkyne [3+2] cycloaddition (CuAAC) between isatin oxime O-propargyl ether and...


Sign in / Sign up

Export Citation Format

Share Document